Burger line Burger line Burger line
Logo Logo Logo
Burger line Burger line Burger line
Menu
Advanced
Wish Lists Wish Lists
Wish Lists Wish Lists
Wish Lists
Cart Cart
Cart Cart
Cart
Sign in
Sign in
Contact us
Advanced
Homepage > Company > Media > Pharma News > 2019

Pharma News, 2019

New pharma Azadyne raises £1.5m for autoimmune disease treatment
New pharma Azadyne raises £1.5m for autoimmune disease treatment
Trinity College’s new spin-out organisation, Azadyne, has completed a £1.
Proteostasis Therapeutics Announces Broad New Dataset from Proprietary Combination and Add-On CFTR Modulator Studies in Cystic Fibrosis Patients
Proteostasis Therapeutics Announces Broad New Dataset from Proprietary Combination and Add-On CFTR Modulator Studies in Cystic Fibrosis Patients
BOSTON, March 25, 2019 /PRNewswire/ -- Proteostasis Therapeutics, Inc.
Seattle Genetics and Astellas Announce Positive Topline Results from Pivotal Trial of Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer
Seattle Genetics and Astellas Announce Positive Topline Results from Pivotal Trial of Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer
BOTHELL, Wash.
Big Pharma accused of 'endless talk, no action' on antibiotic threat
Big Pharma accused of 'endless talk, no action' on antibiotic threat
LONDON (Reuters) - The pharmaceutical industry should match its words with action on researching new antibiotics to address the threat posed by drug-resistant superbugs, a former UK government...
Brain stem cells age faster in multiple sclerosis patients: study
Brain stem cells age faster in multiple sclerosis patients: study
LOS ANGELES, March 26 (Xinhua) -- Brain stem cells in the human body with the most severe form of multiple sclerosis (MS) look much older than they actually are, according to a study l...
Aldeyra Therapeutics Announces Positive Top-Line Results from the Phase 3 ALLEVIATE Trial in Patients with Allergic Conjunctivitis
Aldeyra Therapeutics Announces Positive Top-Line Results from the Phase 3 ALLEVIATE Trial in Patients with Allergic Conjunctivitis
LEXINGTON, Mass.
FDA approval for Mayzent® (siponimod), the first oral drug to treat secondary progressive MS with active disease
FDA approval for Mayzent® (siponimod), the first oral drug to treat secondary progressive MS with active disease
EAST HANOVER, N.
Parasitic worms cause cancer—and could help cure it
Parasitic worms cause cancer—and could help cure it
Billions worldwide are infected with tropical worms.
Can-Fite Announces Phase II Advanced Liver Cancer Top-Line Results for its Orphan/Fast Track Drug Namodenoson
Can-Fite Announces Phase II Advanced Liver Cancer Top-Line Results for its Orphan/Fast Track Drug Namodenoson
PETACH TIKVA, Israel--(BUSINESS WIRE)--Can-Fite BioPharma Ltd.
775 million U.S. dollars: Bayer reaches settlement to resolve Xarelto™ litigation
775 million U.S. dollars: Bayer reaches settlement to resolve Xarelto™ litigation
Leverkusen, March 25, 2019 – More than five years after the Xarelto™ litigation began, and with Bayer and Janssen Pharmaceuticals prevailing in all six cases that went to trial, the companies have...
Early test of male birth control pill shows no safety problems
Early test of male birth control pill shows no safety problems
(Reuters Health) - After taking an experimental male birth control pill for 28 days, 30 men reported no serious side effects and the drug showed signs of decreasing sperm production, according...
Clinical Benefit of Anticancer Drugs Approved by the FDA for Gastrointestinal Malignancies
Clinical Benefit of Anticancer Drugs Approved by the FDA for Gastrointestinal Malignancies
The cost of new anticancer drugs is rising.
0 items in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company
Catalog of Screening Compounds
Screening Libraries
Screening Compounds
Building blocks
Inhibitors and approved drugs
Drug Discovery Services
Custom chemistry. Chemistry FTE. Resynthesis.
Hit Follow up Support
Medicinal chemistry FTE
In silico drug design (CADD)
Discovery Biology. Biology FTE. In vitro studies.
Animal models
Toxicology and safety
ADME, DMPK. In vivo studies
Chemistry, manufacturing and controls
Company
News & Media
Contact us
Trends in discovery compounds